Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Shandong Sanyuan Biotechnology Co Ltd
Total Current Liabilities
Shandong Sanyuan Biotechnology Co Ltd
Total Current Liabilities Peer Comparison
600887
603288
300999
002714
300498
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
S
|
Shandong Sanyuan Biotechnology Co Ltd
SZSE:301206
|
Total Current Liabilities
¥224.2m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Total Current Liabilities
¥76.9B
|
CAGR 3-Years
21%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Total Current Liabilities
¥8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Total Current Liabilities
¥116.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Total Current Liabilities
¥94.7B
|
CAGR 3-Years
26%
|
CAGR 5-Years
45%
|
CAGR 10-Years
55%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Total Current Liabilities
¥31.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Sanyuan Biotechnology Co Ltd's Total Current Liabilities?
Total Current Liabilities
224.2m
CNY
Based on the financial report for Dec 31, 2023, Shandong Sanyuan Biotechnology Co Ltd's Total Current Liabilities amounts to 224.2m CNY.
What is Shandong Sanyuan Biotechnology Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
18%
Over the last year, the Total Current Liabilities growth was 8%. The average annual Total Current Liabilities growth rates for Shandong Sanyuan Biotechnology Co Ltd have been -5% over the past three years , 18% over the past five years .
You don't have any saved screeners yet
